He Muqi said that as a technology company, Merck is studying responsible artificial intelligence and has also set up an ethics committee to define a framework for responsible use of AI. Currently, Merck is educating employees on how to use ChatGPT and understanding the potential and risks of AI. “If I look at it now, I think the application of artificial intelligence in material discovery will make a big difference. Therefore, in terms of drug discovery in the field of medicine and health, we have done a lot, from early development to the end-to-end process of drug development, as well as in the biological manufacturing process. Artificial intelligence will be used both in quality inspection and batch prediction.” He Muqi said that Merck is studying how to help customers and the healthcare industry speed up drug discovery and development through artificial intelligence.